SGRY Stock Analysis: Buy, Sell, or Hold?
SGRY - Surgery Partners, Inc. Common Stock
$15.98
-0.42 (-2.56%)
▼
5d:
-6.0%
30d:
+12.54%
90d:
+23.78%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Smart Money Distribution
None View Scanner →
Strength: 4.8/10
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SGRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SGRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.85
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.78
19.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $15.98, which is considered extended relative to its 30-day fair value range of $13.91 to $16.41. The stock's valuation (Forward PE: 24.4) is in line with its historical norms (25.3). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $14.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.23 (+14.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $14.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.23 (+14.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.91 -
$16.41
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
Protect Your Profits
Holding SGRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($18.23)
- CAUTION: 5-day price weakness (-6.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$13.91 -
$16.41
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$13.09
Resistance Level
$14.21
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.43
Wall Street Target
$18.23
(+14.1%)
Revenue Growth (YoY)
4.5%
Profit Margin
-2.3%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
24.4 vs 25.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$15.79
(-1%)
2-Year Target
$15.60
(-2%)
3-Year Target
$15.41
(-4%)
3-Yr Target (if PE normalizes)
(PE: 24→25)
$15.96
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.4, Growth: 46.4%)
$50.13
(+214%)
Base:
(SPY PE: 21.8, Growth: 46.4%)
$44.70
(+180%)
Bear:
(PE: 18.5, Growth: 46.4%)
$37.99
(+138%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.4 to 25.3
Stabilization Target:
$16.55
(+3.6%)
PE Expansion Potential:
+3.6%
Share & Embed Analysis
Last updated: July 13, 2026 5:40 PM ET
Data refreshes hourly during market hours. Next update: 6:40 PM
Data refreshes hourly during market hours. Next update: 6:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
David T Doherty
SELL
8867 shares
2026-03-16
Jason Eric Evans
SELL
20400 shares
2026-03-16
Danielle Burkhalter
SELL
3469 shares
2026-03-13
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 62 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$494 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 53 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 64 BUY |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
